-------------------------------------------------------------------------------- | | Copenhagen, 25 November 2010 | -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- -------------------------------------------------------------------------------- LifeCycle Pharma A/S - admittance to trading and official listing of new shares due to a rights issue The share capital of LifeCycle Pharma A/S has been increased. The admittance to trading and official listing will take effect on 26 November 2010 in the ISIN below. We refer to the announcements published by LifeCycle Pharma A/S. -------------------------------------------------------------------------------- | ISIN: | DK0060048148 | -------------------------------------------------------------------------------- | Name: | LifeCycle Pharma | -------------------------------------------------------------------------------- | Volume before change: | 56,567,810 shares (DKK 56,567,810) | -------------------------------------------------------------------------------- | Change: | 395,974,670 shares (DKK 395,974,670) | -------------------------------------------------------------------------------- | Volume after change: | 452,542,480 shares (DKK 452,542,480) | -------------------------------------------------------------------------------- | Subscription price, new shares: | DKK 1.20 | -------------------------------------------------------------------------------- | Face value: | DKK 1 | -------------------------------------------------------------------------------- | Short name: | LCP | -------------------------------------------------------------------------------- | Orderbook ID | 36992 | -------------------------------------------------------------------------------- For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66
LifeCycle Pharma A/S - admittance to trading and official listing of new shares due to a rights issue
| Source: Nasdaq Copenhagen A/S
Attachments
